Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“The GAO report found that the DEA does not have any policies or procedures regarding how its staff are to conduct evaluations or schedule substances.”
Mostly supportedConfidence: MODERATE

Reasoning

The Reason.com article cites the GAO report stating that the DEA lacks policies or procedures for staff evaluations and scheduling of substances. This aligns with the claim, providing supporting evidence, though the primary GAO source is not directly examined.

On confidence: The claim is directly quoted in a Reason.com article that references the GAO report, but the original GAO document is not provided, so verification relies on secondary reporting.

Important context

The evidence comes from a news outlet summarizing the GAO findings; the GAO report itself was not accessed, so the exact wording and scope of the GAO's conclusions cannot be confirmed here.

Evidence

Supporting (2)

  • Tier 1 — Primary source
    The way the FDA and DEA ban drugs is unaccountable and arbitrary

    made by the DEA follow a mostly made-up procedure: "DEA does not have any policies or procedures regarding how its staff are to conduct evaluations or schedule substances." Ouch. There aren't any policies? The GAO says that when it asked…

  • Tier 1 — Primary source
    The way the FDA and DEA ban drugs is unaccountable and arbitrary

    Drug Policy The Way the FDA and DEA Ban Drugs Is Unaccountable and Arbitrary A new report from the Government Accountability Office reveals that federal drug regulators do not have any clear policies or procedures for making scheduling…

Limitations

Unable to review the original GAO report; reliance on a secondary source may omit nuances or qualifiers present in the primary document.

Last verified:
Oct 1, 2026, 4:11 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

The Way the FDA and DEA Ban Drugs Is Unaccountable and Arbitrary

Reason · Ryan Curtis